Replies to post #669925 on NorthWest Biotherapeutics Inc (NWBO)

[Idunno]

Ex! Meow.

[jon_k84]

No need to try again, my arguments still hold.

-You would maybe get 5% of company before the price started rocketing.
-No point in buying 10% if your goal is to gain a controlling stake in the company. 51% or bust.
-The “over time” argument is silly. It requires billions in investment capital to get to 51%… no sane company would invest that kind of money and risk the price rocketing by executing the strategy over time. If fact, if what you describe was possible, no company would ever do a buyout ever.

But let’s be honest… you know and agree with all this and just want to be difficult.

[drugrunner]

If EX believes this drug will never be approved .. Then why does he feel the need to post 10k times over 10 years telling us it’s a failure …

Hmmm

Maybe because it will be approved

Maybe because sales may only start in the 100s of millions in year one but scale to 1-5B in next two years 2026-2027

And potentially 10-20b in. 2028-2030

[skitahoe]

If I'm not mistaken, any company taking a 5% or greater position in a company must file that they're doing it. Can you imagine what would happen with the stock if a BP on major Institution announced 5% ownership in NWBO.

I frankly believe that ultimately there will be collaborations on trials between NWBO and BP's and part of the agreements, which the BP's may pay NWBO to do, may have provisions for future stock buys based on the price when certain milestones have been achieved. In short the BP equity partners will be buying at prices that are substantially higher than the price when the collaboration is initially announced.

Gary

[biosectinvestor]

And I previously told you why that would be a stupid move for any BP interested in a deal. It would trigger basically a hostile takeover and a bidding war most likely. It’s no way to actually invest for a serious potential partner as the money is paid to other shareholders and not the company and a negotiated deal can create rights and opportunities that buying shares on the secondary markets cannot possibly trigger. Given the extensive holdings of various persons and friends of the company, as well as other complex relationships that drive some crazy, a hostile buyout for cheap would be a grave mistake.